Pfizer

PFE13F as of Jun 30, 2026 · next update ~Nov 14

#16most bought by top funds in Q2 2026 →

Who's buying PFE

Top funds were split on Pfizer in Q2 (Apr⁠–⁠Jun)

Buying:

Funds6Insiders3Congress

Top funds
6 of 10 bought more, 4 sold some. Largest: Pzena Investment Management, $143.5M (0% of its portfolio).
Insiders
3 insiders bought, 2 sales in 12 months.
Congress
1 member bought (1 trade), 4 sales in 12 months.

10 funds$352.1M held1.3% avg. weightQ2: 6 bought / 4 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 8 filings

Net buying$3.69M

Date	Insider	Type	Shares	Price	Value
Aug 12, 2026	Albert Bourla Chair & CEO	Bought	38,000	$26.34	$1.00M
Aug 5, 2026	Jennifer B. Damico VP & Controller	Sold	3,278	$25.40	$83K
Aug 5, 2026	Ronald E Blaylock Director	Bought	39,231	$25.46	$999K
Aug 5, 2026	Mortimer J Buckley Director	Bought	37,632	$25.52	$960K
Jun 9, 2026	Jennifer B. Damico VP & Controller	Sold	2,000	$25.70	$51K
Mar 4, 2025	Jennifer B. Damico VP & Controller	Sold	2,500	$25.93	$65K
Feb 13, 2025	Ronald E Blaylock Director	Bought	19,457	$25.65	$499K
Oct 30, 2024	Scott Gottlieb Director	Bought	1,000	$28.24	$28K